Chinese Traditional and Herbal Drugs
|
2025, 56(22): 8403-8413
Research progress on traditional Chinese medicine in treatment of inflammatory bowel disease based on gut microbiota-bile acid axis
Full
XIE Yixuan, WEI Xuemei, YANG Yang, LI Yun, WU Jiazhen, LIU Xin, HUANG Yongtong, SU Linqi, ZHANG Yu, GUO Dean, CHEN Qinhua
Affiliations
doi: 10.7501/j.issn.0253-2670.2025.22.029
Outline
Imbalance of the intestinal microbiota is one of the key factors in the onset and progression of inflammatory bowel disease (IBD). The dysbiosis of intestinal microbiota accelerates the pathological process of IBD by disrupting the homeostasis of bile acids metabolism, exacerbating intestinal inflammatory responses and weakening the intestinal mucosal barrier function. As important microbial-host co-metabolites, abnormally metabolized bile acids, such as the accumulated secondary bile acids and elevated production of toxic metabolites, can activate pro-inflammatory signaling pathways. Furthermore, imbalance of bile acid receptor-mediated regulatory networks amplifies the inflammatory cascade reaction and diminishes the protective functions of intestinal immunity and barrier function, thereby forming a vicious cycle of “microbiota-metabolism-immunity”. With its multi-component, multi-target, and multi-pathway synergistic regulatory features, traditional Chinese medicine (TCM) demonstrates unique advantages in the treatment of IBD. It reshapes the structure of the intestinal microbiota, regulates bile acids metabolism, and restores intestinal immune homeostasis. These mechanisms provide new targets for precise intervention in IBD and establish a theoretical foundation for integrated TCM-Western medicine treatment strategies that combine intestinal microecology and metabolic regulation. Based on this, this review systematically explains the core role of the intestinal microbiota-bile acids axis in the pathogenesis of IBD and summarizes the research progress of TCM in multi-dimensional intervention targeting this axis, aiming to open new avenues for the prevention and treatment of IBD.
intestinal microbiota
/
bile acids
/
traditional Chinese medicine
/
inflammatory bowel disease
/
chenodeoxycholic acid
谢译萱, 魏雪梅, 杨洋, 李运, 吴嘉振, 刘馨, 黄泳彤, 苏琳祺, 张瑜, 果德安, 陈琴华.
基于肠道菌群-胆汁酸轴探讨中药治疗炎症性肠病的研究进展.
中草药,
2025
, 56
(22)
: 8403
-8413
.
DOI: 10.7501/j.issn.0253-2670.2025.22.029
XIE Yixuan, WEI Xuemei, YANG Yang, LI Yun, WU Jiazhen, LIU Xin, HUANG Yongtong, SU Linqi, ZHANG Yu, GUO Dean, CHEN Qinhua.
Research progress on traditional Chinese medicine in treatment of inflammatory bowel disease based on gut microbiota-bile acid axis[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(22)
: 8403
-8413
.
DOI: 10.7501/j.issn.0253-2670.2025.22.029
Year 2025 volume 56 Issue 22
65
15
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.22.029
- Receive Date:2025-07-11
- Online Date:2026-11-13